Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining (Q30278665)

14 June 2017

Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining (English)

1 reference

14 June 2017

6

Priya S Kishnani

1 reference

14 June 2017

Harrison N Jones

1

1 reference

14 June 2017

Kelly D Crisp

2

1 reference

14 June 2017

Randall R Robey

3

1 reference

14 June 2017

Laura E Case

4

1 reference

14 June 2017

Richard M Kravitz

5

1 reference

14 June 2017

8 September 2015

1 reference

Molecular Genetics and Metabolism

14 June 2017

1 reference

14 June 2017

117

1 reference

14 June 2017

120-128

1 reference

14 June 2017

2

1 reference

Pompe disease diagnosis and management guideline.

14 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

The genotype-phenotype correlation in Pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Quantitative assessment of lingual strength in late-onset Pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Clinical and histologic ocular findings in pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Late onset Pompe disease: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Supine volume drop and diaphragmatic function in adults with Pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Comparison of Muscle Activities Using a Pressure Biofeedback Unit during Abdominal Muscle Training Performed by Normal Adults in the Standing and Supine Positions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Effects of abdominal hollowing during stair climbing on the activations of local trunk stabilizing muscles: a cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Physical therapy management of Pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

A randomized study of alglucosidase alfa in late-onset Pompe's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Rationale of the combined use of inspiratory and expiratory devices in improving maximal inspiratory pressure and maximal expiratory pressure of patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

The effect of inspiratory and expiratory respiratory muscle training in rowers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Respiratory muscle training in patients with moderate to severe myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Effects of respiratory muscle training (RMT) in children with infantile-onset Pompe disease and respiratory muscle weakness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Consensus treatment recommendations for late-onset Pompe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Single-subject research in rehabilitation: a review of studies using AB, withdrawal, multiple baseline, and alternating treatments designs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

ATS/ERS Statement on respiratory muscle testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

2 Years' experience with inspiratory muscle training in patients with neuromuscular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Inspiratory muscle training in patients with Duchenne muscular dystrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Respiratory muscle training in neuromuscular disease: long-term effects on strength and load perception.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Inspiratory muscle training in the patient with neuromuscular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

Sham device v inert pill: randomised controlled trial of two placebo treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2015.09.003

10.1016/J.YMGME.2015.09.003

7 January 2021

Identifiers

DOI

1 reference

release_agt4wx7aafebxmlgw626wqnlnq

14 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/agt4wx7aafebxmlgw626wqnlnq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference